Stay updated with breaking news from Jesse Shefferman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dosing is progressing well in ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preliminary results expected in 1H24Company init...
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Protara Therapeutics (TARA – Research Report), wit...
Protara Therapeutics (NASDAQ:TARA – Get Rating) and Cardiol Therapeutics (NASDAQ:CRDL – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations and risk. Insider & Institutional Ownership 50.3% of Protara Therapeutics shares […]
Protara Therapeutics (NASDAQ:TARA – Get Rating) and Cardiol Therapeutics (NASDAQ:CRDL – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations and institutional ownership. Analyst Ratings This is a summary of recent ratings […]
Protara Therapeutics (NASDAQ:TARA – Get Rating) and Surrozen (NASDAQ:SRZN – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk. Analyst Recommendations This is a breakdown of current ratings and […]